The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.
Open accessAbstract
Forty-five patients with acute transmural myocardial infarction and angiographically confirmed complete coronary occlusion were prospectively randomized, two for one, to treatment of acute coronary thrombosis with intravenous recombinant human tissue-type plasminogen activator (rt-PA) or placebo. Each of five additional consecutive patients was treated with a high dose of rt-PA for 2 hr. Twenty-five of 33 patients (75%) receiving 0.5 to 0.75 mg/kg of rt-PA over 30 to 120 min had angiographically proven recanalization within 90 min of initiation of therapy. Only one of 14 patients given placebo had spontaneous recanalization within 45 min (p less than .001). Thirteen placebo-treated patients were crossed over to the intracoronary rt-PA group. Nine (69%) exhibited subsequent recanalization within 45 min. Levels of circulating fibrinogen decreased after treatment with rt-PA by an average of only 8% of baseline values. None of the patients manifested a depletion of fibrinogen level to below 100 mg/dl. Six patients who were completely unresponsive to rt-PA were subsequently treated with intracoronary streptokinase and none responded. Thus, either intravenous or intracoronary rt-PA induced coronary thrombolysis without eliciting clinically significant fibrinogenolysis in patients with evolving myocardial infarction due to thrombotic coronary occlusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
Clauss, A. (1957) · Acta Haematologica · doi:10.1159/000205234 · Cited by 3,208
Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction
DeWood, M. A., Spores, J., Notske, R., Mouser, L. T., Burroughs, R., Golden, M. S., & Lang, H. T. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031601 · Cited by 2,740
Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.
Hoylaerts, M., Rijken, D. C., Lijnen, H. R., & Collen, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81051-7 · Cited by 1,312
Self-citationCloning and expression of human tissue-type plasminogen activator cDNA in E. coli
Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., et al. (1983) · Nature · doi:10.1038/301214a0 · Cited by 1,243
Self-citationWestern Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
Kennedy, J. W., Ritchie, J. L., Davis, K. B., & Fritz, J. K. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312153092402 · Cited by 788
A Randomized Trial of Intracoronary Streptokinase in the Treatment of Acute Myocardial Infarction
Anderson, J. L., Marshall, H. W., Bray, B. E., Lutz, J. R., Frederick, P. R., Yanowitz, F. G., Datz, F. L., Klausner, S. C., & Hagan, A. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082202 · Cited by 531
A Rapid, Simple, Sensitive Method for Measuring Fibrinolytic Split Products in Human Serum
Merskey, C., Lalezari, P., & Johnson, A. J. (1969) · Experimental Biology and Medicine · doi:10.3181/00379727-131-33998 · Cited by 415
Khaja, F., Walton, J. A., Brymer, J. F., Lo, E., Osterberger, L., O'Neill, W. W., Colfer, H. T., Weiss, R., Lee, T., Kurian, T., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306023082201 · Cited by 379
Werf, F. V. D., Ludbrook, P. A., Bergmann, S. R., Tiefenbrunn, A. J., Fox, K. A. A., Geest, H. D., Verstraete, M., Collen, D., & Sobel, B. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403083101001 · Cited by 358
Self-citationMatsuo, O., Rijken, D. C., & Collen, D. (1981) · Nature · doi:10.1038/291590a0 · Cited by 248
Self-citationClot-Selective Coronary Thrombolysis with Tissue-Type Plasminogen Activator
Bergmann, S. R., Fox, K. A. A., Ter-Pogossian, M. M., Sobel, B. E., & Collen, D. (1983) · Science · doi:10.1126/science.6602378 · Cited by 237
Self-citationWeimar, W., Stibbe, J., van Seyen, A. J., Billiau, A., Somer, P. D., & Collen, D. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91217-4 · Cited by 149
Self-citationCollen, D., Rijken, D. C., Damme, J. V., & Billiau, A. (1982) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657284 · Cited by 115
Self-citation
Cited by
The Thrombolysis in Myocardial Infarction (TIMI) Trial: Phase I Findings
The TIMI Study Group* (1985) · New England Journal of Medicine · doi:10.1056/nejm198504043121437 · Cited by 3,188
Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., & Ludbrook, P. (1987) · Circulation · doi:10.1161/01.cir.76.1.142 · Cited by 2,244
Self-citationMyocardial reperfusion: a double-edged sword?
Braunwald, E., & Kloner, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112160 · Cited by 1,367
Rao, A. K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T. L., Bell, W. R., Knatterud, G., Robertson, T. L., & Terrin, M. L. (1988) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(88)90158-1 · Cited by 979
Verstraete, M., Bory, M., Collen, D., Erbel, R., Lennane, R. J., Mathey, D., Michels, H. R., Schartl, M., Uebis, R., Bernard, R., et al. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92208-1 · Cited by 750
Self-citation
Metadata
- Authors
- Collen, D., Topol, E. J., Tiefenbrunn, A. J., Gold, H. K., Weisfeldt, M. L., Sobel, B. E., Leinbach, R. C., Brinker, J. A., Ludbrook, P. A., & Yasuda, I.
- Venue
- Circulation
- Published
- 1984-12
- Volume
- 70
- Issue
- 6
- Pages
- 1012-1017
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2041135180
- Cited by
- 378
- References
- 13
- FWCI
- 36.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.